Compare Stocks → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BLUCVE:FNRCVE:SVSNYSE:VTA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsFNR49 North ResourcesC$0.03-14.3%C$0.03C$0.02▼C$0.04C$4.99M0.9260,241 shs113,000 shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shsVTAInvesco Dynamic Credit Opportunities Fund$11.45$11.45$9.16▼$11.99N/AN/A295,911 shsN/A7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%+1.59%FNR49 North Resources0.00%-14.29%+20.00%+20.00%+20.00%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%-16.67%VTAInvesco Dynamic Credit Opportunities Fund0.00%0.00%0.00%0.00%0.00%Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot NowMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/AFNR49 North ResourcesN/AN/AN/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AN/AN/AN/AVTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS HealthN/AN/AN/AN/AFNR49 North ResourcesN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AVTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77FNR49 North ResourcesC$-1.44M-3.46C$0.07 per share0.45C$0.03 per share1.00SVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25VTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/AFNR49 North Resources-C$2.82M-C$0.01N/A∞N/AN/A-29.87%-8.02%6/4/2024 (Estimated)SVSSolarvest BioEnergy-C$2.26M-C$0.04N/A∞N/AN/AN/A-143.12%N/AVTAInvesco Dynamic Credit Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/AFNR49 North ResourcesN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AVTAInvesco Dynamic Credit Opportunities Fund$0.756.55%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42FNR49 North Resources77.280.891.26SVSSolarvest BioEnergyN/AN/A0.02VTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%FNR49 North ResourcesN/ASVSSolarvest BioEnergyN/AVTAInvesco Dynamic Credit Opportunities FundN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%FNR49 North Resources8.31%SVSSolarvest BioEnergy15.85%VTAInvesco Dynamic Credit Opportunities FundN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableFNR49 North ResourcesN/A166.27 millionN/ANot OptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableVTAInvesco Dynamic Credit Opportunities FundN/AN/AN/ANot OptionableFNR, VTA, BLU, SVS, and KZG HeadlinesSourceHeadlineInvesco Rochester Municipal Opportunities Fund;Awsj.com - April 30 at 8:45 PMInvesco Fundamental Alternatives Fund;Awsj.com - February 29 at 10:13 PMInvesco India Liquid Fund Direct Plan Growthlivemint.com - February 17 at 3:24 PMInvesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 1000 Dynamic Multifactor ETF (BATS:OMFL), Quotes and News Summarybenzinga.com - August 25 at 10:42 PMXAXCX Invesco Dynamic Credit Opportunity Fund - Class AX Aseekingalpha.com - August 22 at 4:24 PMInvesco SteelPath MLP Select 40 R6morningstar.com - May 11 at 5:09 AMInvesco India Short Term Fund Direct Growthlivemint.com - April 25 at 1:12 PMInvesco India Liquid Fund Regular Growthlivemint.com - April 20 at 7:32 AMInvesco Diversified Dividend Fund;Investorwsj.com - April 1 at 10:21 PMInvesco India Growth Opportunities Fund Direct Plan Growthlivemint.com - February 16 at 9:24 PMInvesco Value Opportunities Cmorningstar.com - February 11 at 6:42 PMInvesco Value Opportunities R6morningstar.com - February 10 at 3:19 PMInvesco President, CEO Marty Flanagan to Retire; Schlossberg to Take Helm >IVZmarketwatch.com - February 8 at 9:58 AMInvesco Value Opportunities Amorningstar.com - January 25 at 6:21 PMInvesco Value Opportunities Rmorningstar.com - January 21 at 1:14 PMInvesco Rochester® Municipal Opps Amorningstar.com - January 12 at 8:09 PMInvesco DWA Financial Momentum ETF declares quarterly distribution of $0.1102msn.com - December 22 at 1:57 PMInvesco Mortgage Capital Cuts Dividend; Shares Declinemarketwatch.com - September 29 at 12:00 PMAsset manager launches metaverse fundfinextra.com - August 22 at 6:13 AMInvesco Ltd. (IVZ) CEO Marty Flanagan on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - July 27 at 1:38 PMLifeist Reports Q4 And Full Year 2021 Results, Improves Net Loss By 9.84% To $19M YoYbenzinga.com - March 27 at 10:14 PMAlpha Blue Ocean Backs Up Cannabis Co. Halo Collective With $50.7M In Debenture Financingbenzinga.com - March 18 at 11:49 AMFour Lessons From The Legacy Cannabis Market To Dodge Disruptorsbenzinga.com - March 6 at 7:19 PMCybin Teams With Chopra Foundation To Foster Psychedelics Awarenessbenzinga.com - March 5 at 10:41 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Buy the Dip in Netflix Stock, It Won’t Last LongApril 19, 2024 8:32 AMView Buy the Dip in Netflix Stock, It Won’t Last LongIBM Sings the Blues on Mixed Pockets of Strength May 1, 2024 7:00 AMView IBM Sings the Blues on Mixed Pockets of Strength Comprehensive PepsiCo Stock AnalysisApril 18, 2024 12:05 PMView Comprehensive PepsiCo Stock AnalysisAll Headlines Company DescriptionsBELLUS HealthNASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.49 North ResourcesCVE:FNR49 North Resources Inc. is a venture capital firm specializing in seed capital and early stage investments. The firm typically invests in a diversified portfolio of common shares and other securities of resource issuers including all sectors of mineral exploration as well as oil and gas exploration and production around the globe. It focuses on resource issuers with exploration programs in Saskatchewan. The firm also seeks to co-invest. 49 North Resources Inc. was founded in 2005 and is based in Saskatoon, Canada.Solarvest BioEnergyCVE:SVSSolarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.Invesco Dynamic Credit Opportunities FundNYSE:VTAInvesco Dynamic Credit Opportunities Fund is a close-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., Invesco Asset Management Deutschland GmbH, Invesco Asset Management Limited, Invesco Asset Management (Japan) Limited, Invesco Hong Kong Limited, Invesco Senior Secured Management, Inc., and Invesco Canada Ltd. It invests in the fixed income markets across the globe with a focus on the United States. The fund invests in securities of companies that operate across diversified sectors. It invests in fixed income securities such as senior secured floating rate loans, fixed rate loans, and collateralized debt. The fund employs fundamental analysis with a bottom-up security selection process to create its portfolio. It conducts in-house research to make its investments. The fund benchmarks the performance of its portfolio against the Credit Suisse Leveraged Loan Index. It was formerly known as Invesco Van Kampen Dynamic Credit Opportunities Fund. Invesco Dynamic Credit Opportunities Fund was formed on June 26, 2007 and is domiciled in the United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.